Patients With Focal Segmental Glomerulosclerosis Achieved Low Proteinuria Targets Earlier and More Often With Sparsentan vs Irbesartan in DUPLEX

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/0e34d4dbee441a296c23fded94b85b2c.pdf
Patients With Focal Segmental Glomerulosclerosis Achieved Low Proteinuria Targets Earlier and More Often With Sparsentan vs Irbesartan in DUPLEX

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Hernán
Trimarchi
Hernán Trimarchi htrimarchi@hotmail.com British Hospital of Buenos Aires Nephrology Service Buenos Aires Argentina *
Eva Rodríguez García erodriguezg@psmar.cat Equipo Profesional Hospital del Mar Barcelona Spain -
Rasheed Gbadegesin rasheed.gbadegesin@duke.edu Duke University Medical Center Pediatrics Durham United States -
Bruce Hendry bruce.hendry@travere.com Travere Therapeutics, Inc. Medical Affairs San Diego United States -
Jula Inrig jula.inrig@travere.com Travere Therapeutics, Inc. Medical San Diego United States -
Radko Komers radko.komers@travere.com Travere Therapeutics, Inc. Clinical Development, Nephrology San Diego United States -
Laura Kooienga lkooienga@cokidneycare.com Colorado Kidney Care Research Division Denver United States -
Alex Mercer alex.mercer@travere.com JAMCO Pharma Consulting NA Stockholm Sweden -
Edward Murphy edward.murphy@travere.com Travere Therapeutics, Inc. Biostatistics San Diego United States -
Jai Radhakrishnan jr55@cumc.columbia.edu Columbia University Irving Medical Center Division of Nephrology New York United States -
James Tumlin jtumlin@nephronet.com NephroNet Clinical Trials Consortium and Emory University School of Medicine CEO Atlanta United States -
Vladimir Tesar vladimir.tesar@vfn.cz General University Hospital in Prague Department of Nephrology Prague Czech Republic -
-
-
-